Kairos Pharma, Ltd. (KAPA) vs Niki BioSolutions, Inc. (NIKI)

Kairos Pharma, Ltd. and Niki BioSolutions, Inc. are both Biotechnology companies. Kairos Pharma, Ltd. and Niki BioSolutions, Inc. are of similar size ($6.2M and $6.1M). Kairos Pharma, Ltd. has the higher net margin (0.00% vs −921.7%) and the lower return on invested capital (−322.9% vs 0.00%). Across the 10 metrics below, Niki BioSolutions, Inc. leads on 6 and Kairos Pharma, Ltd. on 4.

Valuation

Metric KAPA NIKI Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.26 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 1.25 10.73
Earnings yield (113.92%) (140.76%) (28.84%)
Free cash flow yield (75.40%) 0.00% (23.03%)

Profitability

Metric KAPA NIKI Biotechnology median
Gross margin — (87.96%) 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (921.74%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (113.96%) 0.00% (57.72%)
Return on assets (104.32%) 0.00% (49.22%)
Return on invested capital (322.91%) 0.00% 0.00%

Growth

Metric KAPA NIKI Biotechnology median
Revenue growth (TTM) — 42.64% 5.64%
EPS growth (last fiscal year) (30.44%) 75.64% —
Revenue growth, 5-year CAGR — 2.38% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KAPA NIKI Biotechnology median
Debt to equity 0.00 0.25 0.00
Current ratio 11.98 0.78 4.73
Net debt to EBITDA 1.65 0.02 0.96

Dividend

Metric KAPA NIKI Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric KAPA NIKI Biotechnology median
Market cap 6.13m 6.15m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack